Lodise TP - Search Results

1

The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

van Hal SJ, Lodise TP, Paterson DL. van Hal SJ, et al. Among authors: lodise tp. Clin Infect Dis. 2012 Mar;54(6):755-71. doi: 10.1093/cid/cir935. Epub 2012 Feb 2. Clin Infect Dis. 2012. PMID: 22302374 Review.

2

Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models.

Lodise T, LaPensee K. Lodise T, et al. Am Health Drug Benefits. 2019 Jun-Jul;12(4):168-176. Am Health Drug Benefits. 2019. PMID: 31428234 Free PMC article.

3

Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center.

Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Lodise TP, et al. Clin Infect Dis. 2002 Apr 1;34(7):922-9. doi: 10.1086/339211. Epub 2002 Mar 4. Clin Infect Dis. 2002. PMID: 11880957

4

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.

Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Lodise TP, et al. Clin Infect Dis. 2003 Jun 1;36(11):1418-23. doi: 10.1086/375057. Epub 2003 May 20. Clin Infect Dis. 2003. PMID: 12766837

5

Prediction model to identify patients with Staphylococcus aureus bacteremia at risk for methicillin resistance.

Lodise TP Jr, McKinnon PS, Rybak M. Lodise TP Jr, et al. Infect Control Hosp Epidemiol. 2003 Sep;24(9):655-61. doi: 10.1086/502269. Infect Control Hosp Epidemiol. 2003. PMID: 14510247

6

Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.

Yoo BK, Triller DM, Yong CS, Lodise TP. Yoo BK, et al. Among authors: lodise tp. Ann Pharmacother. 2004 Jul-Aug;38(7-8):1226-35. doi: 10.1345/aph.1E003. Epub 2004 Jun 8. Ann Pharmacother. 2004. PMID: 15187209 Review.

7

Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia.

Lodise TP, McKinnon PS. Lodise TP, et al. Diagn Microbiol Infect Dis. 2005 Jun;52(2):113-22. doi: 10.1016/j.diagmicrobio.2005.02.007. Diagn Microbiol Infect Dis. 2005. PMID: 15964499

8

Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia.

DeRyke CA, Lodise TP Jr, Rybak MJ, McKinnon PS. DeRyke CA, et al. Among authors: lodise tp jr. Chest. 2005 Sep;128(3):1414-22. doi: 10.1378/chest.128.3.1414. Chest. 2005. PMID: 16162737

9

Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy.

Lodise TP Jr, Lomaestro B, Drusano GL. Lodise TP Jr, et al. Clin Infect Dis. 2007 Feb 1;44(3):357-63. doi: 10.1086/510590. Epub 2007 Jan 2. Clin Infect Dis. 2007. PMID: 17205441

10

Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes.

Lodise TP Jr, McKinnon PS. Lodise TP Jr, et al. Pharmacotherapy. 2007 Jul;27(7):1001-12. doi: 10.1592/phco.27.7.1001. Pharmacotherapy. 2007. PMID: 17594206 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results